Navigation Links
Kensey Nash Investor Conference Schedule
Date:8/30/2011

EXTON, Pa., Aug. 30, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in September.

Kensey Nash will be participating at the Barrington Research Growth Conference 2011 in Chicago on Wednesday, September 7th, 2011.  The presentation materials will be available on the company's website (www.kenseynash.com) at 8:00 a.m. ET on Wednesday, September 7th, 2011.

Michael Celano, Kensey Nash's Chief Financial Officer, will deliver the Company's presentation, at the CL King's 9th Annual Best Ideas Conference at the Omni Berkshire Place Hotel in New York on Tuesday, September 13th, 2011 at 3:45 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.videonewswire.com/event.asp?id=81468.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 3:45 p.m. (ET) on Tuesday, September 13th, 2011.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 21st, 2011 beginning at approximately at 9:00 a.m. (ET).  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Wednesday, September 21st, 2011.

Joseph W. Kaufmann will deliver the Company's presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27th, 2011 beginning approximately at 10:00 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/jeff62/knsy/.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 10:00 p.m. (ET) on Tuesday, September 27th, 2011.

About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit www.kenseynash.com.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results
2. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference
3. Kensey Nash Announces New Unsecured Revolving Credit Facility
4. Kensey Nash to Present at the Jefferies 2011 Global Healthcare Conference
5. Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
6. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
7. Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
8. Kensey Nash Announces a Manufacturing Agreement with and Minority Investment in Orteq Sports Medicine
9. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
10. Kensey Nash to Present at Two Investor Conferences in November
11. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):